Article and Video CATEGORIES
Denise has over 30 years of varying experience in the healthcare arena. In August 2009 she joined The Global Resource for Advancing Cancer Education as one of its first employees. She has grown with the organization and now oversees the operational movement of programs, efficiency, and effectiveness within the organization, as well as the daily processes and functions.
Immunotherapy and Combination Treatment Updates, SCLC, and Early and Locally Advanced NSCLC
Join GRACE for this annual Live Online event featuring the top oncologists in their field discussing the most current Lung Cancer Updates and Treatments, and answering patient questions live.
Register Now to Join the Global Resource for Advancing Cancer Education for 3 LiveOnline panel discussions covering updates on Immunotherapy and Combination Treatments, Small Cell Lung Cancer, and Early and Locally Advanced Non Small Cell Lung Cancer. Opportunities for questions will be available at the end of each panel discussion.
The latest information about GRACE events will always be available at www.cancergrace.org.
If you have any questions regarding your registration, please email us at info@cancerGRACE.org.
We look forward to having you join us! Stay safe and healthy!
Join GRACE Live ONLINE December 5, 2020, 8 AM Pacific
Register Below for the GRACE 2020 OncTalk - Connecting Patients to the Experts!
This event will be held LIVE ONLINE
For Details - Please View the full Agenda and the Faculty Information for more information!
Please feel free to offer comments and raise questions in our
discussion forums.
Related Content
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Hello Linda, my name is Alexandra Beneke, I'm the Outreach Manager for GRACE. Your willingness to share your experiences and knowledge with the cancer community is truly inspiring. Your dedication to...
Recent Comments
That's…